These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11751780)

  • 1. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients.
    Cohen E; Dadashev A; Drucker M; Samra Z; Rubinstein E; Garty M
    J Antimicrob Chemother; 2002 Jan; 49(1):155-60. PubMed ID: 11751780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.
    Elting LS; Rubenstein EB; Kurtin D; Rolston KV; Fangtang J; Martin CG; Raad II; Whimbey EE; Manzullo E; Bodey GP
    Cancer; 1998 Dec; 83(12):2597-607. PubMed ID: 9874468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections.
    Karachalios GN; Houpas P; Tziviskou E; Papalimneou V; Georgiou A; Karachaliou I; Halkiadaki D
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):561-4. PubMed ID: 9799062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-weekly dalbavancin versus daily conventional therapy for skin infection.
    Boucher HW; Wilcox M; Talbot GH; Puttagunta S; Das AF; Dunne MW
    N Engl J Med; 2014 Jun; 370(23):2169-79. PubMed ID: 24897082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose oritavancin in the treatment of acute bacterial skin infections.
    Corey GR; Kabler H; Mehra P; Gupta S; Overcash JS; Porwal A; Giordano P; Lucasti C; Perez A; Good S; Jiang H; Moeck G; O'Riordan W;
    N Engl J Med; 2014 Jun; 370(23):2180-90. PubMed ID: 24897083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once versus thrice daily gentamicin in patients with serious infections.
    Prins JM; Büller HR; Kuijper EJ; Tange RA; Speelman P
    Lancet; 1993 Feb; 341(8841):335-9. PubMed ID: 8094114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.
    Rostas SE; Kubiak DW; Calderwood MS
    Clin Ther; 2014 Jul; 36(7):1098-101. PubMed ID: 24931573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
    Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
    Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients.
    Marik PE; Lipman J; Kobilski S; Scribante J
    J Antimicrob Chemother; 1991 Nov; 28(5):753-64. PubMed ID: 1778878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.
    Blaser J; Simmen HP; Thurnheer U; König C; Lüthy R
    J Antimicrob Chemother; 1995 Nov; 36(5):803-14. PubMed ID: 8626261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Level of evidence for therapeutic drug monitoring of vancomycin].
    Jelassi ML; Benlmouden A; Lefeuvre S; Mainardi JL; Billaud EM;
    Therapie; 2011; 66(1):29-37. PubMed ID: 21466775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild nephrotoxicity associated with vancomycin use.
    Downs NJ; Neihart RE; Dolezal JM; Hodges GR
    Arch Intern Med; 1989 Aug; 149(8):1777-81. PubMed ID: 2764651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Top Guns: The "Maverick" and "Goose" of Empiric Therapy.
    Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Sawyer RG
    Surg Infect (Larchmt); 2016 Feb; 17(1):38-47. PubMed ID: 26484854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intravenous vancomycin in children with normal renal function hospitalized in hematology-oncology: prospective validation of a dosing regimen optimizing steady-state concentration.
    Hoegy D; Goutelle S; Garnier N; Rénard C; Faure-Conter C; Bergeron C; Bertrand Y; Bleyzac N
    Fundam Clin Pharmacol; 2018 Jun; 32(3):323-329. PubMed ID: 29315849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Rates of Nephrotoxicity Associated with Vancomycin in Combination with Piperacillin-Tazobactam Administered as an Extended versus Standard Infusion.
    Mousavi M; Zapolskaya T; Scipione MR; Louie E; Papadopoulos J; Dubrovskaya Y
    Pharmacotherapy; 2017 Mar; 37(3):379-385. PubMed ID: 28079263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-Associated Nephrotoxicity: The Obesity Factor.
    Davies SW; Efird JT; Guidry CA; Dietch ZC; Willis RN; Shah PM; Hennessy SA; Sawyer RG
    Surg Infect (Larchmt); 2015 Dec; 16(6):684-93. PubMed ID: 26324996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials.
    Kasiakou SK; Sermaides GJ; Michalopoulos A; Soteriades ES; Falagas ME
    Lancet Infect Dis; 2005 Sep; 5(9):581-9. PubMed ID: 16122681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
    Gendeh BS; Gibb AG; Aziz NS; Kong N; Zahir ZM
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):551-8. PubMed ID: 9560111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.